Storti, S., Spina, M., Pesce, E. A., Salvi, F., Merli, M., Ruffini, A., . . . Luminari, S. (2018). Rituximab plus bendamustine as front-line treatment in frail elderly (>70 years) patients with diffuse large B-cell non-Hodgkin lymphoma: A phase II multicenter study of the Fondazione Italiana Linfomi. Haematologica.
Chicago Style citaatStorti, Sergio, et al. "Rituximab Plus Bendamustine As Front-line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi." Haematologica 2018.
MLA citatieStorti, Sergio, et al. "Rituximab Plus Bendamustine As Front-line Treatment in Frail Elderly (>70 Years) Patients With Diffuse Large B-cell Non-Hodgkin Lymphoma: A Phase II Multicenter Study of the Fondazione Italiana Linfomi." Haematologica 2018.